217 related articles for article (PubMed ID: 24786788)
1. Oncogenic protein MTBP interacts with MYC to promote tumorigenesis.
Grieb BC; Gramling MW; Arrate MP; Chen X; Beauparlant SL; Haines DS; Xiao H; Eischen CM
Cancer Res; 2014 Jul; 74(13):3591-602. PubMed ID: 24786788
[TBL] [Abstract][Full Text] [Related]
2. An ATPase/helicase complex is an essential cofactor for oncogenic transformation by c-Myc.
Wood MA; McMahon SB; Cole MD
Mol Cell; 2000 Feb; 5(2):321-30. PubMed ID: 10882073
[TBL] [Abstract][Full Text] [Related]
3. A deficiency in Mdm2 binding protein inhibits Myc-induced B-cell proliferation and lymphomagenesis.
Odvody J; Vincent T; Arrate MP; Grieb B; Wang S; Garriga J; Lozano G; Iwakuma T; Haines DS; Eischen CM
Oncogene; 2010 Jun; 29(22):3287-96. PubMed ID: 20305689
[TBL] [Abstract][Full Text] [Related]
4. MTBP regulates cell survival and therapeutic sensitivity in TP53 wildtype glioblastomas.
Song Y; Zhang L; Jiang Y; Hu T; Zhang D; Qiao Q; Wang R; Wang M; Han S
Theranostics; 2019; 9(20):6019-6030. PubMed ID: 31534534
[No Abstract] [Full Text] [Related]
5. BAF53 forms distinct nuclear complexes and functions as a critical c-Myc-interacting nuclear cofactor for oncogenic transformation.
Park J; Wood MA; Cole MD
Mol Cell Biol; 2002 Mar; 22(5):1307-16. PubMed ID: 11839798
[TBL] [Abstract][Full Text] [Related]
6. MTBP is overexpressed in triple-negative breast cancer and contributes to its growth and survival.
Grieb BC; Chen X; Eischen CM
Mol Cancer Res; 2014 Sep; 12(9):1216-24. PubMed ID: 24866769
[TBL] [Abstract][Full Text] [Related]
7. Pontin and Reptin regulate cell proliferation in early Xenopus embryos in collaboration with c-Myc and Miz-1.
Etard C; Gradl D; Kunz M; Eilers M; Wedlich D
Mech Dev; 2005 Apr; 122(4):545-56. PubMed ID: 15804567
[TBL] [Abstract][Full Text] [Related]
8. MTBP and MYC: A Dynamic Duo in Proliferation, Cancer, and Aging.
Grieb BC; Eischen CM
Biology (Basel); 2022 Jun; 11(6):. PubMed ID: 35741402
[TBL] [Abstract][Full Text] [Related]
9. Myc interacts genetically with Tip48/Reptin and Tip49/Pontin to control growth and proliferation during Drosophila development.
Bellosta P; Hulf T; Balla Diop S; Usseglio F; Pradel J; Aragnol D; Gallant P
Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11799-804. PubMed ID: 16087886
[TBL] [Abstract][Full Text] [Related]
10. Haploinsufficiency of the Myc regulator Mtbp extends survival and delays tumor development in aging mice.
Grieb BC; Boyd K; Mitra R; Eischen CM
Aging (Albany NY); 2016 Oct; 8(10):2590-2602. PubMed ID: 27803394
[TBL] [Abstract][Full Text] [Related]
11. TIP49, but not TRRAP, modulates c-Myc and E2F1 dependent apoptosis.
Dugan KA; Wood MA; Cole MD
Oncogene; 2002 Aug; 21(38):5835-43. PubMed ID: 12185582
[TBL] [Abstract][Full Text] [Related]
12. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.
Kim J; Roh M; Abdulkadir SA
BMC Cancer; 2010 Jun; 10():248. PubMed ID: 20515470
[TBL] [Abstract][Full Text] [Related]
13. The non-enzymatic RAS effector RASSF7 inhibits oncogenic c-Myc function.
Kumaraswamy A; Mamidi A; Desai P; Sivagnanam A; Perumalsamy LR; Ramakrishnan C; Gromiha M; Rajalingam K; Mahalingam S
J Biol Chem; 2018 Oct; 293(40):15691-15705. PubMed ID: 30139745
[No Abstract] [Full Text] [Related]
14. MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.
Kalkat M; Resetca D; Lourenco C; Chan PK; Wei Y; Shiah YJ; Vitkin N; Tong Y; Sunnerhagen M; Done SJ; Boutros PC; Raught B; Penn LZ
Mol Cell; 2018 Dec; 72(5):836-848.e7. PubMed ID: 30415952
[TBL] [Abstract][Full Text] [Related]
15. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.
Aprelikova O; Chen K; El Touny LH; Brignatz-Guittard C; Han J; Qiu T; Yang HH; Lee MP; Zhu M; Green JE
Clin Epigenetics; 2016; 8():38. PubMed ID: 27081402
[TBL] [Abstract][Full Text] [Related]
16. Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation.
Li Z; Boone D; Hann SR
Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18794-9. PubMed ID: 19033198
[TBL] [Abstract][Full Text] [Related]
17. MTBP Promotes the Invasion and Metastasis of Hepatocellular Carcinoma by Enhancing the MDM2-Mediated Degradation of E-Cadherin.
Lu S; Zhou W; Wei H; He L; Li L
Dig Dis Sci; 2015 Dec; 60(12):3681-90. PubMed ID: 26280083
[TBL] [Abstract][Full Text] [Related]
18. MTBP suppresses cell migration and filopodia formation by inhibiting ACTN4.
Agarwal N; Adhikari AS; Iyer SV; Hekmatdoost K; Welch DR; Iwakuma T
Oncogene; 2013 Jan; 32(4):462-70. PubMed ID: 22370640
[TBL] [Abstract][Full Text] [Related]
19. MTBP inhibits migration and metastasis of hepatocellular carcinoma.
Bi Q; Ranjan A; Fan R; Agarwal N; Welch DR; Weinman SA; Ding J; Iwakuma T
Clin Exp Metastasis; 2015 Apr; 32(4):301-11. PubMed ID: 25759210
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.
Meng X; Carlson NR; Dong J; Zhang Y
Oncogene; 2015 Nov; 34(46):5709-17. PubMed ID: 25823025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
